The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy.
Mogensen CE, Christensen CK, Vittinghus E.
Diabetes. 1983 May;32 Suppl 2:64-78. doi: 10.2337/diab.32.2.s64.
Diabetic nephropathy.
Ritz E.
Saudi J Kidney Dis Transpl. 2006 Dec;17(4):481-90.
Diabetic nephropathy.
Ibrahim HA, Vora JP.
Baillieres Best Pract Res Clin Endocrinol Metab. 1999 Jul;13(2):239-64. doi: 10.1053/beem.1999.0018.
Benefits and cost of antihypertensive treatment in incipient and overt diabetic nephropathy.
Parving HH.
J Hypertens Suppl. 1998 Jan;16(1):S99-101.
The effects of dual and triple combinations of trandolapril, telmisartan, and verapamil on overt proteinuria in the patients with diabetic nephropathy.
Albayrak B, Cankaya E, Cetinkaya R, Cerrah S, Bilen Y.
Saudi J Kidney Dis Transpl. 2016 May;27(3):512-8. doi: 10.4103/1319-2442.182385.
Losartan in diabetic nephropathy.
Perico N, Ruggenenti P, Remuzzi G.
Expert Rev Cardiovasc Ther. 2004 Jul;2(4):473-83. doi: 10.1586/14779072.2.4.473.
Effects of the SGLT2 inhibitor ipragliflozin on various diabetic symptoms and progression of overt nephropathy in type 2 diabetic mice.
Tahara A, Takasu T.
Naunyn Schmiedebergs Arch Pharmacol. 2018 Apr;391(4):395-406. doi: 10.1007/s00210-018-1469-5. Epub 2018 Jan 26.
Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy.
Wu CC, Chen JS, Lu KC, Chen CC, Lin SH, Chu P, Sytwu HK, Lin YF.
Clin Chim Acta. 2010 May 2;411(9-10):700-4. doi: 10.1016/j.cca.2010.01.036. Epub 2010 Feb 4.
The role of CDH2 and MCP-1 mRNAs of blood extracellular vesicles in predicting early-stage diabetic nephropathy.
Dehghanbanadaki H, Forouzanfar K, Kakaei A, Zeidi S, Salehi N, Arjmand B, Razi F, Hashemi E.
PLoS One. 2022 Apr 1;17(4):e0265619. doi: 10.1371/journal.pone.0265619. eCollection 2022.
Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-beta and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study.
Khajehdehi P, Pakfetrat M, Javidnia K, Azad F, Malekmakan L, Nasab MH, Dehghanzadeh G.
Scand J Urol Nephrol. 2011 Nov;45(5):365-70. doi: 10.3109/00365599.2011.585622. Epub 2011 May 31.
